Can Proteomics Transform Cancer Prevention? Learn from Dr. Stefánsson at PMWC Feb 5-7 – Healthcare Professional
Can we predict and prevent cancer before it strikes? Dr. Kári Stefánsson, founder of deCODE Genetics, is leading the way.
Join me at the Precision Medicine World Conference (PMWC) 2025 – Feb 5-7 Silicon Valley for an exclusive session where Dr. Stefánsson reveals groundbreaking research on genetic variants shaping cancer risk and prevention.
On Feb. 7th, in Track 4 of PMWC 2025, Dr. Stefánsson will present his latest findings in proteomics, examining how protein levels in blood correlate with disease progression and regression. This innovative approach goes beyond treating symptoms to address the molecular roots of diseases, paving the way for tailored therapies.
Key Highlights of Dr. Stefánsson’s Research:
• Critical insights into cancer risk: Genetic variants in genes like BIK and ATG12 increase cancer risk by 90-295%.
• Protective genetic variants: Loss of PPP1R15A reduces breast cancer risk by 53%, while AURKB loss offers protection against multiple cancer types.
• Clinical integration of genetic data: Learn how cutting-edge discoveries can transform cancer treatment and prevention strategies.
Dr. Stefánsson’s work not only identifies genetic factors increasing cancer risk but also uncovers variants that reduce it, offering exciting new avenues for therapy and prevention. This session will illuminate how these findings can reshape clinical practices and patient outcomes.
Join the discussion at the Santa Clara Convention Center, Feb. 5-7 and save by end of year!
Shaping the future of precision medicine!
Happy Holidays,
Tal Behar
President & Co-founder, PMWC
PMWC 2025 Silicon Valley – February 5-7, 2025
The Precision Medicine World Conference
